Filing Details

Accession Number:
0001127602-12-032228
Form Type:
4
Zero Holdings:
No
Publication Time:
2012-11-28 20:16:02
Reporting Period:
2012-11-26
Filing Date:
2012-11-28
Accepted Time:
2012-11-28 20:16:02
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
850693 Allergan Inc AGN Pharmaceutical Preparations (2834) 951622442
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1158587 R Michael Gallagher 2525 Dupont Drive
Irvine CA 92612
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2012-11-19 47,700 $0.00 47,700 No 5 G Indirect By Gallagher Family Trust
Common Stock Disposition 2012-11-19 47,700 $0.00 17,500 No 5 G Direct
Common Stock Disposition 2012-11-20 8,700 $0.00 8,800 No 5 G Direct
Common Stock Disposition 2012-11-26 4,700 $91.20 43,000 No 4 S Indirect By Gallagher Family Trust
Common Stock Disposition 2012-11-27 11,802 $91.93 31,198 No 4 S Indirect By Gallagher Family Trust
Common Stock Acquisiton 2012-11-27 5,000 $45.89 13,800 No 4 M Direct
Common Stock Acquisiton 2012-11-27 5,000 $36.49 18,800 No 4 M Direct
Common Stock Acquisiton 2012-11-27 10,632 $46.66 29,432 No 4 M Direct
Common Stock Disposition 2012-11-27 20,632 $92.07 8,800 No 4 S Direct
Common Stock Acquisiton 2012-11-28 768 $46.66 9,568 No 4 M Direct
Common Stock Acquisiton 2012-11-28 9,000 $51.72 18,568 No 4 M Direct
Common Stock Disposition 2012-11-28 9,768 $91.29 8,800 No 4 S Direct
Common Stock Disposition 2012-11-28 3,598 $91.68 27,600 No 4 S Indirect By Gallagher Family Trust
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 5 G Indirect By Gallagher Family Trust
No 5 G Direct
No 5 G Direct
No 4 S Indirect By Gallagher Family Trust
No 4 S Indirect By Gallagher Family Trust
No 4 M Direct
No 4 M Direct
No 4 M Direct
No 4 S Direct
No 4 M Direct
No 4 M Direct
No 4 S Direct
No 4 S Indirect By Gallagher Family Trust
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Nonemployee Director Stock Option (Right to Buy) Disposition 2012-11-27 5,000 $0.00 5,000 $45.89
Common Stock Nonemployee Director Stock Option (Right to Buy) Disposition 2012-11-27 5,000 $0.00 5,000 $36.49
Common Stock Nonemployee Director Stock Option (Right to Buy) Disposition 2012-11-27 10,632 $0.00 10,632 $46.66
Common Stock Nonemployee Director Stock Option (Right to Buy) Disposition 2012-11-28 768 $0.00 768 $46.66
Common Stock Nonemployee Director Stock Option (Right to Buy) Disposition 2012-11-28 9,000 $0.00 9,000 $51.72
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
0 2005-04-28 2014-04-28 No 4 M Direct
0 2006-04-26 2015-04-26 No 4 M Direct
768 2019-04-30 No 4 M Direct
0 2019-04-30 No 4 M Direct
0 2007-05-02 2016-05-02 No 4 M Direct
Footnotes
  1. Transfer of 47,700 shares held directly by the reporting person to the Gallagher Family Trust.
  2. Shares held by the Gallagher Family Trust. Reporting Person is trustee of the Gallagher Family Trust.
  3. The price reported in Column 4 is the weighted average price. These shares were sold in multiple transactions at prices ranging from $91.00 to $91.42, inclusive. The reporting person undertakes to provide Allergan, Inc., any security holder of Allergan, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the range set forth in this footnote.
  4. The price reported in Column 4 is the weighted average price. These shares were sold in multiple transactions at prices ranging from $91.75 to $92.35, inclusive. The reporting person undertakes to provide Allergan, Inc., any security holder of Allergan, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the range set forth in this footnote.
  5. The price reported in Column 4 is the weighted average price. These shares were sold in multiple transactions at prices ranging from $92.00 to $92.35, inclusive. The reporting person undertakes to provide Allergan, Inc., any security holder of Allergan, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the range set forth in this footnote.
  6. The price reported in Column 4 is the weighted average price. These shares were sold in multiple transactions at prices ranging from $91.25 to $91.36, inclusive. The reporting person undertakes to provide Allergan, Inc., any security holder of Allergan, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the range set forth in this footnote.
  7. The price reported in Column 4 is the weighted average price. These shares were sold in multiple transactions at prices ranging from $91.50 to $91.88, inclusive. The reporting person undertakes to provide Allergan, Inc., any security holder of Allergan, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the range set forth in this footnote.
  8. Option is fully vested and exercisable upon the earlier to occur (i) the first anniversary of the grant date, or (ii) the annual meeting held during such calendar year at which one or more members of the board are standing for re-election following the date of grant.